- Market Radar
- /
- CABA
Sagehood
Financial Analyst
PREMIUM
Technical Trader
PREMIUM
Valuation Projection
PREMIUM
Social Media Buzz
PREMIUM
News Agent
PREMIUM
Macro Economist
PREMIUM
About CABA
7/28/2025
Comprehensive Analysis
Financial Health
- Liquidity & Solvency: Cabaletta Bio (CABA) maintains a robust current ratio of 6.15 (2024) and quick ratio of 6.05, with cash reserves of $164M (post-raise, $400M pro forma). Low debt (debt-to-equity ~0.06) and no interest obligations reduce solvency risk.
Free Insights for Smarter Investing
Get 5 daily AI-powered insights on your favorite stocks-absolutely free.
Free Account
- View 5 tickers daily
- Create and manage Watchlists
- Import portfolios (no personalized insights)
- Chat with the general Sagehood AI Agent
- Market Radar: Preview access only
Premium Membership
- Unlimited AI-generated insights across all sections
- Market Overview
- Market Radar (AI-driven investment opportunities)
- Access to all Sagehood AI agents, including domain-specific experts
- Personalized insights and actionable recommendations for smarter investing